Axa S.A. Ionis Pharmaceuticals Inc Transaction History
Axa S.A.
- $32.3 Billion
- Q3 2024
A detailed history of Axa S.A. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Axa S.A. holds 561,243 shares of IONS stock, worth $19.3 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
561,243
Previous 464,963
20.71%
Holding current value
$19.3 Million
Previous $22.2 Million
1.46%
% of portfolio
0.07%
Previous 0.07%
Shares
32 transactions
Others Institutions Holding IONS
# of Institutions
403Shares Held
136MCall Options Held
862KPut Options Held
582K-
Vanguard Group Inc Valley Forge, PA15.1MShares$517 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$487 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$354 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.74MShares$300 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$270 Million5.32% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.87B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...